EAM
Eagle Asset Management Portfolio holdings
AUM
$19.6B
1-Year Return
41.7%
This Quarter Return
+32.81%
1 Year Return
+41.7%
3 Year Return
+53.51%
5 Year Return
+214.43%
10 Year Return
+692.81%
AUM
$17.6B
AUM Growth
+$1.51B
(+9.4%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-11.99%
Top 10 Holdings %
Top 10 Hldgs %
10.02%
Holding
655
New
43
Increased
228
Reduced
288
Closed
92
Top Buys
| 1 |
Target
TGT
|
$110M |
| 2 |
Broadcom
AVGO
|
$81.9M |
| 3 |
ResMed
RMD
|
$77.6M |
| 4 |
Union Pacific
UNP
|
$57M |
| 5 |
West Pharmaceutical
WST
|
$47.8M |
Top Sells
| 1 |
Zoetis
ZTS
|
$125M |
| 2 |
Woodward
WWD
|
$103M |
| 3 |
Wingstop
WING
|
$102M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
$94.1M |
| 5 |
Centene
CNC
|
$90.1M |
Sector Composition
| 1 | Technology | 24.57% |
| 2 | Healthcare | 23.13% |
| 3 | Industrials | 13.38% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Builders FirstSource
BLDR
$16.5B
| $22.8M | 0.13% |
1,112,803
-591,950
| -35% | -$12.1M |
|
202
Brink's
BCO
$4.78B
| $22.7M | 0.13% |
495,830
-239,590
| -33% | -$11M |
|
203
Nice
NICE
$8.67B
| $22.4M | 0.13% |
120,502
+741
| +0.6% | +$138K |
|
204
PTC Therapeutics
PTCT
$4.55B
| $22M | 0.12% |
433,935
+233,212
| +116% | +$11.8M |
|
205
Simpson Manufacturing
SSD
$8.15B
| $21.9M | 0.12% |
265,165
+144,071
| +119% | +$11.9M |
|
206
Qualys
QLYS
$4.87B
| $21.8M | 0.12% |
215,785
-50,318
| -19% | -$5.07M |
|
207
Columbia Banking Systems
COLB
$8.05B
| $21.8M | 0.12% |
785,376
+193,572
| +33% | +$5.36M |
|
|
MYOK
208
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $21.7M | 0.12% |
+224,486
| New | +$21.7M |
|
209
Terreno Realty
TRNO
$6.1B
| $21.4M | 0.12% |
409,174
+8,063
| +2% | +$423K |
|
|
NVRO
210
DELISTED
NEVRO CORP.
NVRO
| $21.3M | 0.12% |
+180,357
| New | +$21.3M |
|
211
Abbott
ABT
$231B
| $20.8M | 0.12% |
233,977
-75,527
| -24% | -$6.72M |
|
212
NOV
NOV
$4.95B
| $20.6M | 0.12% |
1,694,205
+7,050
| +0.4% | +$85.7K |
|
213
Ultragenyx Pharmaceutical
RARE
$3.07B
| $20.3M | 0.12% |
+275,247
| New | +$20.3M |
|
214
Evolent Health
EVH
$1.11B
| $19.8M | 0.11% |
2,893,510
-245,350
| -8% | -$1.68M |
|
215
eHealth
EHTH
$125M
| $19.8M | 0.11% |
207,690
-125,184
| -38% | -$11.9M |
|
216
Bandwidth Inc
BAND
$473M
| $19.8M | 0.11% |
157,078
-55,384
| -26% | -$6.97M |
|
217
HealthEquity
HQY
$7.88B
| $19.3M | 0.11% |
332,617
-55,776
| -14% | -$3.24M |
|
218
Iovance Biotherapeutics
IOVA
$901M
| $19.3M | 0.11% |
708,660
+275,325
| +64% | +$7.49M |
|
219
Texas Roadhouse
TXRH
$11.2B
| $19.2M | 0.11% |
362,377
+22,329
| +7% | +$1.18M |
|
220
Houlihan Lokey
HLI
$13.9B
| $18.9M | 0.11% |
350,127
+38,397
| +12% | +$2.07M |
|
221
Caesars Entertainment
CZR
$5.48B
| $18.9M | 0.11% |
477,225
+227,870
| +91% | +$9.02M |
|
222
Littelfuse
LFUS
$6.51B
| $18.8M | 0.11% |
112,113
+429
| +0.4% | +$72K |
|
223
AtriCure
ATRC
$1.76B
| $18.4M | 0.1% |
414,029
+308,408
| +292% | +$13.7M |
|
224
Albany International
AIN
$1.84B
| $17.9M | 0.1% |
304,790
+27,821
| +10% | +$1.63M |
|
225
Bio-Techne
TECH
$8.46B
| $17.8M | 0.1% |
281,240
+5,096
| +2% | +$323K |
|